|
|
Hall A : OPENING SESSION; PLENARY LECTURES
|
09:00
|
Welcome remarks and invitation to CONy 2017
Amos D. Korczyn, Israel
|
|
|
|
|
09:00
|
Welcome remarks and invitation to CONy 2017
Victor Oliveira, Portugal
|
|
|
|
|
09:30
|
Egas Moniz and his role in 20th century neurology
Victor Oliveira, Portugal
|
|
|
|
Hall A : PLENARY LECTURES ON STROKE
|
11:00
|
Late-Onset Dementias and Alzheimer's Desease: Can they be prevented.
Lefkos T. Middleton, Great Britain
|
|
|
|
|
11:30
|
Shifting the paradigm in brain protection and recovery
Dafin Muresanu, Romania
|
|
|
|
|
12:00
|
Role of exosomes/miRNA in mediating recovery after stroke and traumatic brain injury
Michael Chopp, USA
|
|
|
|
|
12:30
|
Post-stroke cerebral reorganization
Jay P. Mohr, USA
|
|
|
|
Hall A : PLENARY LECTURES
|
13:45
|
Can the brain be really understood?
Richard Frackowiak, Switzerland
|
|
|
|
|
14:15
|
Vagus nerve stimulation: Headache and beyond
Stephen Silberstein, USA
|
|
|
|
|
14:45
|
Redefining neurological diseases through epigenetics
Tiago Fleming Outeiro, Germany
|
|
|
|
Hall A : PLENARY LECTURES ON ALZHEIMER'S DISEASE
|
16:30
|
Is AD caused by viral infection?
Ruth Itzhaki, UK
|
|
|
|
|
17:00
|
Debate: Is beta-amyloid still a relevant target in AD therapy?
Host: Michael Geschwind , USA
|
|
|
|
|
17:25
|
Debate: Is beta-amyloid still a relevant target in AD therapy?
No: Amos Korczyn, Israel
|
|
|
|
|
17:40
|
Debate: Is beta-amyloid still a relevant target in AD therapy?
Discussion and rebuttal
|
|
|